4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-026157
Director sold 136,436 shares at an average $34.31 ($4,681,653)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schroeder Thilo Director | 2021-04-06 | Sale | −11,571 | $33.85 | $391,678 | 2,261,332 | I: show line 1 in the form |
| Schroeder Thilo Director | 2021-04-06 | Sale | −67,086 | $34.67 | $2,325,872 | 2,194,246 | I: show line 2 in the form |
| Schroeder Thilo Director | 2021-04-07 | Sale | −24,357 | $33.88 | $825,215 | 2,169,889 | I: show line 3 in the form |
| Schroeder Thilo Director | 2021-04-07 | Sale | −100 | $34.50 | $3,450 | 2,169,789 | I: show line 4 in the form |
| Schroeder Thilo Director | 2021-04-08 | Sale | −12,621 | $33.82 | $426,842 | 2,157,168 | I: show line 5 in the form |
| Schroeder Thilo Director | 2021-04-08 | Sale | −20,701 | $34.23 | $708,595 | 2,136,467 | I: show line 6 in the form |
| Open-market sales · 136,436 sh · avg $34.31 · $4,681,653 | |||||||
Loading xslF345X03/doc4.xml…